# Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes

> **NCT00992511** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 300 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK investigational vaccine GSK2340272A
- **BIOLOGICAL:** GSK investigational vaccine GSK2340272A
- **BIOLOGICAL:** GSK investigational vaccine GSK2340272A
- **BIOLOGICAL:** GSK investigational vaccine GSK2340272A

## Key facts

- **NCT ID:** NCT00992511
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-14
- **Primary completion:** 2010-11-09
- **Final completion:** 2010-11-09
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00992511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00992511, "Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00992511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*